Biogen Names New GM for RTP Operations

Durham-base pharmaceutical firm Biogen has named Joydeep Ganguly General Manager for the company's RTP operations.

Quintiles and Biogen Announce Partnership

Durham's Quintiles and Biogen, two biopharmaceutical companies with major presences in the region have announced a five-year collaboration agreement in order to improve Biogen's clinical development process.

Biogen Idec Foundation Grant to Help Durham STEM Students

Durham middle school students in a science, technology, engineering and math (STEM) apprenticeship program will receive academic mentoring as part of a new grant from the Biogen Idec Foundation.

Triangle Business Journal Honors 2013 Leaders in Diversity

The Triangle Business Journal has honored its 2013 Leaders in Diversity, which include Durham mayor Bill Bell and Biogen Idec.

Durham Schools Receive Biogen Grants

Durham's Biogen Idec Foundation in collaboration with Triangle Community Foundation announced it has awarded 28 grants totaling $48,914.55 to Triangle area schools (seven from Durham) and nonprofits as part of its Micro-Grants in Science Education program. The program provides small, one-time grants ranging from $250 - $2,500 to schools and nonprofits to support science education initiatives.

Biogen Idec, Eisai to partner in RTP

Biogen Idec will be using Research Triangle Park facilities of Eisai Inc., the U.S. pharmaceutical business of a Japanese company, to make oral, solid dose products such as tablets through a partnership announced Wednesday.

Biogen Idec Opening New Building in RTP

This week Biogen Idec will celebrate the opening of its newest building on its Research Triangle Park Campus, a 190,000-square-foot Bio26 administration building.